|
| 36692396 | MRI Quantification of Cortical Bone Porosity, Mineralization, and Morphologic Structure in Postmenopausal Osteoporosis. | Radiology | 2023 |
| 37804846 | Symptomatic benefits of testosterone treatment in patient subgroups: a systematic review, individual participant data meta-analysis, and aggregate data meta-analysis. | Lancet Healthy Longev | 2023 |
| 37680892 | Long-term efficacy and safety of osilodrostat in patients with Cushing's disease: results from the LINC 4 study extension. | Front Endocrinol (Lausanne) | 2023 |
| 36958542 | Automated, calibration-free quantification of cortical bone porosity and geometry in postmenopausal osteoporosis from ultrashort echo time MRI and deep learning. | Bone | 2023 |
| 37236354 | Testosterone Treatment of Men with Unequivocal Hypogonadism Following Treatment of Organ-Confined Prostate Cancer. | Endocr Pract | 2023 |
| 35266057 | Testosterone treatment of late-onset hypogonadism - benefits and risks. | Rev Endocr Metab Disord | 2022 |
| 35783127 | Avoid or Embrace? Practice Effects in Alzheimer's Disease Prevention Trials. | Front Aging Neurosci | 2022 |
| 35711614 | Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis. | Lancet Healthy Longev | 2022 |
| 36309420 | What We Have Learned from The Testosterone Trials. | Urol Clin North Am | 2022 |
| 36244691 | Symptoms of Late-Onset Hypogonadism in Men. | Endocrinol Metab Clin North Am | 2022 |
| 35099509 | Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. | JAMA Neurol | 2022 |
| 35041751 | Relation of Testosterone, Dihydrotestosterone, and Estradiol With Changes in Outcomes Measures in the Testosterone Trials. | J Clin Endocrinol Metab | 2022 |
| 35124638 | A Neuropsychological Perspective on Defining Cognitive Impairment in the Clinical Study of Alzheimer's Disease: Towards a More Continuous Approach. | J Alzheimers Dis | 2022 |
| 35216713 | The Benefits and Risks of Testosterone Treatment in Older Hypogonadal Men. | Endocrinol Metab Clin North Am | 2022 |
| 34877782 | Characteristics of subjective cognitive decline associated with amyloid positivity. | Alzheimers Dement | 2022 |
| 35325149 | Randomized Trial of Osilodrostat for the Treatment of Cushing Disease. | J Clin Endocrinol Metab | 2022 |
| 33210287 | Clinically Important Differences for Mobility Measures Derived from the Testosterone Trials. | J Am Geriatr Soc | 2021 |
| 33684655 | The relationship between cerebral and retinal microbleeds in cerebral amyloid angiopathy (CAA): A pilot study. | J Neurol Sci | 2021 |
| 33848348 | T4DM Trial and its T4Bone Substudy Shed Further Light on Effects of Testosterone Treatment in Middle-Aged and Older Men. | J Clin Endocrinol Metab | 2021 |
| 34797188 | Exploring Effects of Aerobic Exercise and Mindfulness Training on Cognitive Function in Older Adults at Risk of Dementia: A Feasibility, Proof-of-Concept Study. | Am J Alzheimers Dis Other Demen | 2021 |
| 34155411 | A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease. | Nat Med | 2021 |
| 34341456 | OCTA reveals remodeling of the peripheral capillary free zones in normal aging. | Sci Rep | 2021 |
| 33314313 | Effect of Low-Intensity Vibration on Bone Strength, Microstructure, and Adiposity in Pre-Osteoporotic Postmenopausal Women: A Randomized Placebo-Controlled Trial. | J Bone Miner Res | 2021 |
| 33226732 | Alzheimer's team care approach-akin to diabetes-in the development, validation, and population assessment of retinal biomarkers for disease. | Alzheimers Dement | 2021 |
| 32296740 | Ectopic Prolactin Secretion From a Uterine Leiomyoma. | J Endocr Soc | 2020 |
| 31784747 | Biomarkers and Noncalcified Coronary Artery Plaque Progression in Older Men Treated With Testosterone. | J Clin Endocrinol Metab | 2020 |
| 31914228 | Retinal imaging think tank convened by the Alzheimer's Association to examine its promise in the early detection of Alzheimer's. | Alzheimers Dement | 2020 |
| 31914225 | Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward. | Alzheimers Dement | 2020 |
| 33163610 | A recommended "minimum data set" framework for SD-OCT retinal image acquisition and analysis from the Atlas of Retinal Imaging in Alzheimer's Study (ARIAS). | Alzheimers Dement (Amst) | 2020 |
| 33134766 | Prostate-Specific Antigen Concentrations in Response to Testosterone Treatment of Severely Hypogonadal Men. | J Endocr Soc | 2020 |
| 32775596 | Clearance of interstitial fluid (ISF) and CSF (CLIC) group-part of Vascular Professional Interest Area (PIA): Cerebrovascular disease and the failure of elimination of Amyloid-β from the brain and retina with age and Alzheimer's disease-Opportunities for Therapy. | Alzheimers Dement (Amst) | 2020 |
| 32785689 | Markers of Iron Flux during Testosterone-Mediated Erythropoiesis in Older Men with Unexplained or Iron-Deficiency Anemia. | J Clin Endocrinol Metab | 2020 |
| 32209123 | Disruption of cholinergic neurotransmission, within a cognitive challenge paradigm, is indicative of Aβ-related cognitive impairment in preclinical Alzheimer's disease after a 27-month delay interval. | Alzheimers Res Ther | 2020 |
| 30924399 | Sensitivity of a Preclinical Alzheimer's Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer's disease. | J Clin Exp Neuropsychol | 2019 |
| 31768414 | Blood-based biomarkers for Alzheimer's disease and related dementias: Keys to success and things to consider. | Alzheimers Dement (Amst) | 2019 |
| 31736739 | A Potential Association Between Retinal Changes, Subjective Memory Impairment, and Anxiety in Older Adults at Risk for Alzheimer's Disease: A 27-Month Pilot Study. | Front Aging Neurosci | 2019 |
| 31504596 | Prostate-Specific Antigen Levels During Testosterone Treatment of Hypogonadal Older Men: Data from a Controlled Trial. | J Clin Endocrinol Metab | 2019 |
| 31101538 | Clinically Meaningful Change in Sexual Desire in the Psychosexual Daily Questionnaire in Older Men from the TTrials. | J Sex Med | 2019 |
| 29253154 | The Effect of Testosterone on Cardiovascular Biomarkers in the Testosterone Trials. | J Clin Endocrinol Metab | 2018 |
| 30103330 | Episodic Memory and Learning Dysfunction Over an 18-Month Period in Preclinical and Prodromal Alzheimer's Disease. | J Alzheimers Dis | 2018 |
| 29960633 | Validity and Clinically Meaningful Changes in the Psychosexual Daily Questionnaire and Derogatis Interview for Sexual Function Assessment: Results From the Testosterone Trials. | J Sex Med | 2018 |
| 29955660 | Discontinuation and nonpublication of interventional clinical trials conducted in patients with mild cognitive impairment and Alzheimer's disease. | Alzheimers Dement (N Y) | 2018 |
| 29850777 | The cholinergic system in the pathophysiology and treatment of Alzheimer's disease. | Brain | 2018 |
| 30366567 | Effect of testosterone replacement on measures of mobility in older men with mobility limitation and low testosterone concentrations: secondary analyses of the Testosterone Trials. | Lancet Diabetes Endocrinol | 2018 |
| 29780864 | Change in retinal structural anatomy during the preclinical stage of Alzheimer's disease. | Alzheimers Dement (Amst) | 2018 |
| 29522088 | Lessons From the Testosterone Trials. | Endocr Rev | 2018 |
| 29562364 | Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. | J Clin Endocrinol Metab | 2018 |
| 29559907 | Use of Eflornithine (DFMO) in the Treatment of Early Alzheimer's Disease: A Compassionate Use, Single-Case Study. | Front Aging Neurosci | 2018 |
| 27870940 | Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic. | Alzheimers Dement | 2017 |
| 28275702 | Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis. | Alzheimers Dement (Amst) | 2017 |